Table 2.
Predicted association of proton pump inhibitors (PPIs) with cancer, neoplasm, and tumor.
Proton Pump Inhibitor (PPI) | Number of PubMed Citations | Normalized Association | |
---|---|---|---|
PPI | PPI and (Cancer OR Neoplasm OR Tumor) | ||
Omeprazole | 13,796 | 1621 | 0.12 * |
Lansoprazole | 3232 | 390 | 0.12 * |
Pantoprazole | 2407 | 246 | 0.10 * |
Esomeprazole | 2044 | 214 | 0.10 * |
Rabeprazole | 1543 | 143 | 0.09 |
Dexlansoprazole | 166 | 13 | 0.08 |
Famotidine (H2R blocker) | 2519 | 210 | 0.08 * |
* Statistically significant.